Literature DB >> 8522262

Possible metaplastic origin of lymph node "metastases" in serous ovarian tumor of low malignant potential (borderline serous tumor).

N Kadar1, M Krumerman.   

Abstract

A patient with a stage III serous ovarian carcinoma of low malignant potential (borderline serous tumor) is described who had extensive involvement of the pelvic and para-aortic lymph nodes by both borderline tumor and endosalpingiosis. Transition from endosalpingiosis to papillary serous borderline tumor was demonstrable in multiple intranodal sites, and in fully developed lesions, areas of metaplastic growth acquired a desmoplastic stroma. This finding suggests that the lymph node "metastases" may have arisen de novo by neoplastic transformation of preexistent metaplastic tubal-type epithelium (endosalpingiosis), and would lend further credence to the metaplastic (rather than metastatic) origin or extraovarian implants in serous ovarian carcinoma of low malignant potential.

Entities:  

Mesh:

Year:  1995        PMID: 8522262     DOI: 10.1006/gyno.1995.9955

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases.

Authors:  Kruti P Maniar; Yihong Wang; Kala Visvanathan; Ie-Ming Shih; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

Review 2.  The cell of origin of ovarian epithelial tumours.

Authors:  Louis Dubeau
Journal:  Lancet Oncol       Date:  2008-12       Impact factor: 41.316

Review 3.  Coming into focus: the nonovarian origins of ovarian cancer.

Authors:  L Dubeau; R Drapkin
Journal:  Ann Oncol       Date:  2013-11       Impact factor: 32.976

4.  Vaginal Endosalpingiosis: A Case Report and Literature Review.

Authors:  Ahmed Sabri; Margarita Loxas; Linnea Banker; Kevin Zhang; Wayne Penka
Journal:  Cureus       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.